Cargando…

HOW TO HARNESS NEW IMMUNOTHERAPIES WITH COMBINATION STRATEGIES?

Detalles Bibliográficos
Autor principal:	Einsele, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Main Program
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171739/ http://dx.doi.org/10.1097/01.HS9.0000936092.62707.d5

Ejemplares similares

IMMUNOTHERAPY
por: Einsele, Hermann
Publicado: (2022)

TREATMENT OF TRIPLE-CLASS REFRACTORY DISEASE: BEYOND IMMUNOTHERAPY
por: Gavriatopoulou, M.
Publicado: (2023)

HOW TO INCORPORATE MRD IN CLINICAL TRIALS
por: San-Miguel, Jesus
Publicado: (2022)

HOW TO TREAT UNFIT AND FRAIL PATIENTS
por: Cook, Gordon
Publicado: (2022)

HOW TO TREAT HIGH RISK PATIENTS
por: Kaiser, Martin
Publicado: (2022)

THE ATLAS INITIATIVE AND HOW TO IMPROVE ACCESS FOR PATIENTS
por: Morgan, Kate
Publicado: (2022)

COVID-19 AND MYELOMA
por: Ludwig, H, et al.
Publicado: (2022)

MASS SPECTROMETRY AS A TOOL FOR MINIMAL RESIDUAL DISEASE DETECTION IN THE BLOOD OF MYELOMA PATIENTS
por: Jacobs, J.F.M.
Publicado: (2023)

AL AMYLOIDOSIS UPFRONT TREATMENT AND CURRENT AND FUTURE STUDIES
por: Kastritis, E.
Publicado: (2023)

EARLY DETECTION AND SCREENING FOR MULTIPLE MYELOMA PRECURSORS
por: Thorsteinsdottir, S.
Publicado: (2023)

BONE DISEASE
por: Terpos, E.
Publicado: (2023)

MGRS: DIAGNOSIS AND TREATMENT
por: Bridoux, F.
Publicado: (2023)

ANTIBODY DRUG CONJUGATES (ADCS)
por: Terpos, E.
Publicado: (2023)

MONOCLONAL GAMMOPATHY OF CLINICAL SIGNIFICANCE
por: Bladé, J.
Publicado: (2023)

DEBATE UPFRONT vs DELAYED TRANSPLANT
por: Gay, F.
Publicado: (2023)

FROM BENIGN TO MALIGNANT DISEASE
por: Bolli, Niccolò
Publicado: (2022)

MINIMAL RESIDUAL DISEASE IN PERIPHERAL BLOOD ASSESSED BY MASS SPECTROMETRY
por: Puig, Noemi
Publicado: (2022)

DRUGGABLE MM THERAPEUTICS: PATHOGENETIC PATHWAYS
por: Ocio, Enrique M
Publicado: (2022)

LIGHT CHAIN DEPOSITION DISEASE
por: Vos, Josephine M.I.
Publicado: (2022)

BONE DISEASE
por: Terpos, Evangelos
Publicado: (2022)

EXTRAMEDULLARY DISEASE
por: Beksac, Meral
Publicado: (2022)

AL AMYLOIDOSIS: MECHANISMS OF DISEASE AND BIOMARKERS
por: Palladini, Giovanni, et al.
Publicado: (2022)

CIRCULATING TUMOR CELLS
por: Paiva, Bruno
Publicado: (2022)

TREATMENT AT RELAPSE: WHAT TO DO FIRST?
por: Mateos, Maria-Victoria
Publicado: (2022)

Cognitive appraisals of dissociation in psychosis: a new brief measure
por: Černis, Emma, et al.
Publicado: (2021)

Escalation strategies for combination therapy Phase I trials
por: Sweeting, Michael J, et al.
Publicado: (2012)

A compassionate imagery intervention for patients with persecutory delusions
por: Forkert, Ava, et al.
Publicado: (2022)

Are young people with primary social anxiety disorder less likely to recover following generic CBT compared to young people with other primary anxiety disorders? A systematic review and meta-analysis
por: Evans, Rachel, et al.
Publicado: (2021)

Understanding agoraphobic avoidance: the development of the Oxford Cognitions and Defences Questionnaire (O-CDQ)
por: Rosebrock, Laina, et al.
Publicado: (2022)

An overview of pivotal trials and real-world evidence for CD20-depleting therapy in multiple sclerosis: Immunotherapy with rituximab, ocrelizumab, and ofatumumab
por: Ovchinnikov, Arkady, et al.
Publicado: (2022)

Adopting AI: how familiarity breeds both trust and contempt
por: Horowitz, Michael C., et al.
Publicado: (2023)

SCI: A Bayesian adaptive phase I/II dose‐finding design accounting for semi‐competing risks outcomes for immunotherapy trials
por: Zhang, Yifei, et al.
Publicado: (2022)

Program
Publicado: (2011)

Program
Publicado: (2011)

Program
Publicado: (2010)

Dose‐escalation strategies which use subgroup information
por: Cotterill, Amy, et al.
Publicado: (2018)

Management strategies in heart failure with preserved ejection fraction
por: Wintrich, Jan, et al.
Publicado: (2022)

Oncocardiology: new challenges, new opportunities
por: Michel, Lars, et al.
Publicado: (2020)

Delayed treatment effects, treatment switching and heterogeneous patient populations: How to design and analyze RCTs in oncology
por: Ristl, Robin, et al.
Publicado: (2020)

Coronavirus disease 2019 related parosmia: an exploratory survey of demographics and treatment strategies
por: Sowerby, L J, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_509p9bk97ot081nqrmf9d32d04